PMDA Presents Views on Efficacy, Safety Evaluations for Domestic Development of COVID-19 Vaccines

The Pharmaceuticals and Medical Devices Agency (PMDA) presented on September 2 its current views on the efficacy and safety required of COVID-19 vaccines being developed in Japan, saying “As a rule, clinical trials must evaluate candidate vaccines’ efficacy for preventing...read more